Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

1(13%)

Results Posted

67%(2 trials)

Terminated

1(13%)

Phase Distribution

Ph phase_3

13%

Ph phase_2

25%

Ph not_applicable

25%

Ph phase_1

38%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

3(37.5%)

Phase 2Efficacy & side effects

2(25.0%)

Phase 3Large-scale testing

1(12.5%)

N/ANon-phased studies

2(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Terminated(1)

Other(2)

Detailed Status

Completed3

unknown2

Not yet recruiting1

Recruiting1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 3

Trials by Phase

Phase 13 (37.5%)

Phase 22 (25.0%)

Phase 31 (12.5%)

N/A2 (25.0%)

Trials by Status

not_yet_recruiting113%

unknown225%

completed338%

recruiting113%

terminated113%

Recent Activity

1 active trials

Showing 5 of 8

recruitingnot_applicable

Emotional Intelligence Intervention to Improve Mental Well-Being of Adolescents With Emotional Distress (BEAM)

NCT06713460

completedphase_2

A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial)

NCT02278796

not_yet_recruitingphase_2

Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL

NCT06652165

unknownphase_3

A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

NCT01827605

completedphase_1

Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's Lymphoma

NCT00574509

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT06713460Not Applicable

Emotional Intelligence Intervention to Improve Mental Well-Being of Adolescents With Emotional Distress (BEAM)

Recruiting

NCT02278796Phase 2

A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial)

Completed

NCT06652165Phase 2

Zanubrutinib Combined With BEAM for ASCT in Relapsed and Refractory DLBCL

Not Yet Recruiting

NCT01827605Phase 3

A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

Unknown

NCT00574509Phase 1

Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's Lymphoma

Completed

NCT00572013Phase 1

Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma

Completed

NCT05814718Not Applicable

Modified BEAM Regimen for T Cell Lymphoma Underwent ASCT

Unknown

NCT01468311Phase 1

Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma

Terminated

All 8 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 8